Phospho-HSF1 (Thr142) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Form
Rabbit IgG in phosphate-buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, 150 mM NaCl, 0.02% sodium azide, and 50% glycerol.
Lead Time
Product dispatch occurs within 1–3 business days of order receipt. Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Synonyms
Heat shock factor 1 antibody; Heat shock factor protein 1 antibody; Heat shock transcription factor 1 antibody; HSF 1 antibody; hsf1 antibody; HSF1_HUMAN antibody; HSTF 1 antibody; HSTF1 antibody
Target Names
HSF1
Uniprot No.

Target Background

Function

Heat shock factor 1 (HSF1) functions as a stress-inducible, DNA-binding transcription factor crucial for activating the heat shock response (HSR). This activation leads to the expression of heat shock proteins (HSPs), molecular chaperones that protect cells from damage caused by various cellular insults. Under normal conditions, HSF1 exists in an inactive, monomeric form within a HSP90-containing multichaperone complex, preventing DNA binding. Exposure to stressors such as heat triggers HSF1 homotrimerization, enabling it to bind to heat shock elements (HSEs) in HSP gene promoters and initiate transcription. This activation is reversible; during HSR attenuation, HSF1 returns to its inactive state. HSF1 binds to inverted 5'-NGAAN-3' pentamer DNA sequences and chromatin at heat shock gene promoters. Beyond transcriptional regulation, HSF1 performs other functions. It represses Ras-induced c-fos gene activation in heat-stressed cells, positively regulates HSP70 mRNA 3'-end processing and polyadenylation (in a symplekin-dependent manner), facilitates the nuclear export of stress-induced HSP70 mRNA, modulates mitotic progression, and negatively regulates non-homologous end joining (NHEJ) DNA repair (in a DNA damage-dependent manner). Furthermore, HSF1 is involved in stress-induced cancer cell proliferation (IER5-dependent) and latent HIV-1 transcriptional reactivation by binding to the HIV-1 long terminal repeat (LTR) promoter and recruiting transcriptional elongation factors like CDK9, CCNT1, and EP300.

Gene References Into Functions
  • HSF1 shows strong association with gastric cancer cell proliferation, motility, and poor patient prognosis, suggesting its potential as a prognostic marker. PMID: 30328318
  • HSF1 positively regulates latent HIV transcription. PMID: 27189267
  • Significantly reduced HSF1 levels are observed in Huntington's Disease (HD). PMID: 28194040
  • Cellular mosaicism in Hsf1 heat shock signaling activation contributes to variations in brain defects. PMID: 28462912
  • HSF1 participates in diverse stress-induced cellular processes and molecular mechanisms. PMID: 29774376
  • Upon DNA damage, activated and auto-poly-ADP-ribosylated PARP1 dissociates from HSF1-PARP13 and relocates to DNA lesions and DNA damage-inducible gene loci. PMID: 29158484
  • Overexpressed HSF1 triggers pre-mRNA 3' processing in cancers. PMID: 29268782
  • High HSF1 expression in intrahepatic cholangiocarcinoma tumor tissues may serve as a prognostic biomarker. PMID: 29278438
  • HSF1 integrates diverse biological and pathological responses. PMID: 28890254
  • The single nucleotide polymorphism rs78202224 (G>T) is significantly associated with increased breast cancer risk. PMID: 29494616
  • HSF1 down-regulates ArgBP2, providing insight into the HSF1 & MORC2-PRC2-ArgBP2 signaling pathway and its functions in gastric cancer cells. PMID: 29339121
  • HSF1 activation at Ser326 and HSP27 transcription are linked to the maintenance of gynecological cancer stem cells/cancer-initiating cells. PMID: 28415561
  • HSF1 is a key transcription factor inducing DNAJB8 and SOX2 expression; cellular stress induces cancer stem-like cells via DNAJB8 expression through HSF1 activation. PMID: 29316077
  • Heat shock transcription factor 1 (HSF1) mRNA expression levels in ER-positive breast cancer correlate with shorter relapse-free and overall survival. PMID: 27713164
  • HSF1 functions as a novel oncogene in pancreatic tumors, suggesting its potential as a diagnostic and therapeutic target. PMID: 28482903
  • High HSF1 expression is observed in malignant epithelial ovarian cancer tissues (serous, mucinous, endometrioid, and clear cell). PMID: 28487934
  • miR-487a, mediated by HSF1, promotes hepatocellular carcinoma (HCC) proliferation and metastasis through PIK3R1 and SPRED2 binding, suggesting its potential as a prognostic marker or therapeutic target. PMID: 27827315
  • HSF1 activity is decreased in fibrotic hearts; HSF1 inhibits Smad3 phosphorylation and nuclear distribution by direct binding, and active Smad3 counteracts HSF1's anti-fibrotic effect. PMID: 28091697
  • Targeting HSF1 activation in combination with bortezomib may enhance multiple myeloma treatment efficacy. PMID: 27487129
  • Molecular dynamics simulations reveal post-translational modification-dependent conformational changes in HSF1-DNA interactions. PMID: 27882499
  • 1,4-NQ activates HSF1, upregulating downstream genes like HSPA6. Per/polysulfides mitigate 1,4-NQ reactivity by forming sulfur adducts. PMID: 28049024
  • Casein kinase 1 phosphorylates SQSTM1 S349 when harmful proteins accumulate under HSF1 stress. PMID: 27846364
  • HSF1 plays an essential role in TERRA transcriptional activation and telomere protection under stress. PMID: 28369628
  • HSF1-dependent chaperone mechanisms clear acetylation-triggered TDP-43 pathology in cells and mouse skeletal muscle. PMID: 28724966
  • Low glucose inhibits hepatocellular carcinoma cell EMT-like morphological changes, cadherin switching, and cell migration by persistently down-regulating HSF1 and snail1 expression. PMID: 27755964
  • piR-823 enhances HSF1 transcriptional activity by binding and promoting Ser326 phosphorylation. PMID: 28618124
  • HSF1 increases ATG4B gene promoter activity and binds to its promoter region (-1429 to -1417). PMID: 28889000
  • HSF1 knockdown reduces osteosarcoma cell proliferation, migration, and invasion, while overexpression promotes these processes. PMID: 28370690
  • Correlations exist between HSF1 activity and the incidence of various cancers. PMID: 27225066
  • HSF1 is important in the ovarian cancer TGFβ response and Epithelial-Mesenchymal Transition (EMT). PMID: 27997575
  • BRD4 regulates splicing during heat shock by interacting with HSF1; under heat stress, BRD4 is recruited to nuclear stress bodies, upregulating SatIII RNA transcripts. PMID: 27536004
  • p38 MAPK phosphorylates HSF1 at S326 and S303/307, transcriptionally activating HSF1. PMID: 27354066
  • HSF1 translationally augments the proteotoxic stress response. PMID: 27043084
  • HSF1 depletion sensitizes A172 glioblastoma cells to temozolomide by suppressing cancer stem cell-like properties. PMID: 28241425
  • HCA induces BAG3 expression via HSF1 activation; BAG3 knockdown largely inhibits HCA-induced apoptosis. PMID: 27922674
  • miR-34b suppresses AML cell proliferation and survival by targeting HSF1 and inactivating the Wnt-β-catenin pathway. PMID: 27296951
  • Genetic associations exist for multivariate response phenotypes involving trans effects modulating gene expression after heat shock, including HSF1 and UBQLN1. PMID: 27553423
  • M3-mAChR activation enhances hsp expression via PKC-dependent HSF1 phosphorylation, stabilizing mutant hERG-FLAG protein; M3-mAChR activators may be therapeutically valuable for LQT2 patients. PMID: 27803431
  • Oncogenic signaling mobilizes HSF1; cancer cells rely on HSF1 to prevent proteomic instability and repress tumor-suppressive amyloidogenesis. PMID: 26597576
  • An IER5-mediated cancer regulation pathway activates HSF1 in various cancers. PMID: 26754925
  • Temperature-dependent Hsf1 unfolding in the regulatory region occurs concurrently with tighter packing in the trimerization region. PMID: 26785146
  • Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expression. PMID: 26427350
  • Aberrant HSF1 degradation is a key neurodegenerative mechanism in α-synucleinopathy; elevated NEDD4 is implicated as the responsible ubiquitin E3 ligase. PMID: 26503960
  • High HSF1 expression is associated with acute myeloid leukemia (AML). PMID: 26473447
  • Glucose induces HSF1 phosphorylation at S326 and upregulates downstream αB-crystallin and Hsp70 expression. PMID: 26010766
  • Tonantzitlolone (TZL) induces PKCθ-dependent HSF1 phosphorylation. PMID: 26298773
  • HSF1 interacts with Ku70 and Ku86 to induce defective NHEJ repair and genomic instability. PMID: 26359349
  • Early Hsf1-dependent cell stress pathway activation by mono-allelic APC mutations may contribute to cancer onset. PMID: 26320184
  • Cocrystal structures of the human HSF1 DNA-binding domain complexed with cognate DNA have been determined. PMID: 26727489
  • HSF1 phosphorylation at Ser230 is responsible for Hsp70-1 upregulation during coxsackieviral infection. PMID: 26361762
Database Links

HGNC: 5224

OMIM: 140580

KEGG: hsa:3297

STRING: 9606.ENSP00000431512

UniGene: Hs.530227

Protein Families
HSF family
Subcellular Location
Nucleus. Cytoplasm. Nucleus, nucleoplasm. Cytoplasm, perinuclear region. Cytoplasm, cytoskeleton, spindle pole. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore.

Q&A

What is Phospho-HSF1 (Thr142) and what biological role does this phosphorylation site play?

Phospho-HSF1 (Thr142) refers to Heat Shock Factor 1 protein that has been phosphorylated at the threonine residue at position 142. HSF1 functions as a stress-inducible DNA-binding transcription factor central to transcriptional activation of the heat shock response . The phosphorylation at Thr142 has dual regulatory effects - it can both activate and inhibit HSF1 function depending on cellular context and the presence of other modifications.

From a mechanistic perspective, AKT1 phosphorylates HSF1 at Thr142, which enables trimerization of HSF1 molecules . This trimerization is essential for HSF1's DNA-binding activity and subsequent activation of heat shock genes. The phosphorylation status at this site changes dynamically during stress response, with heat shock generally increasing phosphorylation of HSF1 by 2.5 to 4-fold compared to non-stressed conditions .

How do I select the appropriate Phospho-HSF1 (Thr142) antibody for my experiments?

When selecting a Phospho-HSF1 (Thr142) antibody, consider these methodological criteria:

  • Specificity confirmation: Choose antibodies that specifically detect HSF1 only when phosphorylated at Thr142, not total HSF1 or other phosphorylation sites. Look for validation data showing the antibody detects "endogenous levels of HSF1 only when phosphorylated at Thr142" .

  • Application compatibility: Different experimental techniques require different antibody properties. For example:

    • For IHC applications, typically use dilutions of 1:50-1:100

    • For ELISA applications, typically use dilutions around 1:20000

  • Species reactivity: Ensure the antibody reacts with your experimental model organism. Most commercially available Phospho-HSF1 (Thr142) antibodies react with human and mouse HSF1 .

  • Validation method: Review how the antibody was validated - ideally through peptide competition assays, where a phospho-peptide containing Thr142 blocks antibody binding, confirming specificity .

What are the typical applications for Phospho-HSF1 (Thr142) antibodies in research?

Phospho-HSF1 (Thr142) antibodies have several methodological applications in research:

  • Immunohistochemistry (IHC): Used to visualize and localize phosphorylated HSF1 in tissue sections. This helps determine how stress or experimental treatments affect HSF1 phosphorylation status in different tissue types and cell populations .

  • Immunofluorescence (IF): Enables subcellular visualization of phosphorylated HSF1, particularly its nuclear translocation and formation of nuclear stress granules following activation .

  • ELISA: Provides quantitative measurement of phosphorylated HSF1 levels in cellular extracts, allowing for high-throughput analysis across multiple samples and experimental conditions .

  • Monitoring stress response activation: Used to track the activation state of the heat shock response pathway by measuring phosphorylation at Thr142 as a biomarker of HSF1 activation .

  • Investigating signaling pathways: Applied to study kinase pathways like AKT1 that regulate HSF1 activity through phosphorylation at Thr142 .

How does phosphorylation at Thr142 interact with other HSF1 post-translational modifications?

HSF1 undergoes extensive post-translational modifications that work in concert to regulate its activity. Thr142 phosphorylation interacts with other modifications in complex ways:

What methodological approaches can resolve contradictory data regarding Thr142 phosphorylation effects?

To resolve contradictory data regarding the effects of Thr142 phosphorylation on HSF1 function, researchers should consider:

  • Site-specific mutagenesis: Generate T142A (non-phosphorylatable) and T142E/D (phosphomimetic) mutants to directly test the functional consequences of phosphorylation at this site in different cellular contexts. Compare to approaches used for other sites, such as the S230A mutation that showed reduced activity compared to wild-type HSF1 .

  • Temporal analysis: Implement time-course studies using phospho-specific antibodies to track Thr142 phosphorylation during different phases of stress response. This is particularly important as HSF1 regulation is highly dynamic, with phosphorylation status changing rapidly following stress exposure .

  • Combinatorial mutation analysis: Create HSF1 mutants with combinations of modified phosphorylation sites to understand how Thr142 interacts with other phosphorylation events. This approach can reveal whether contradictory effects result from different patterns of multi-site phosphorylation.

  • Cell type and stress-specific analysis: Systematically compare Thr142 phosphorylation effects across different cell types and stress conditions, as regulatory mechanisms may be context-dependent.

  • Kinase and phosphatase identification: Use kinase inhibitors, phosphatase inhibitors, and knockdown/overexpression approaches to identify the specific enzymes regulating Thr142 phosphorylation under different conditions. For example, examining whether AKT1 overexpression enhances both phosphorylation and HSF1 activity .

How can phospho-HSF1 (Thr142) antibodies be validated for specificity in experimental systems?

Rigorous validation of phospho-HSF1 (Thr142) antibodies requires multiple complementary approaches:

  • Peptide competition assays: Pre-incubate the antibody with a phosphopeptide containing the Thr142 sequence. This should block antibody detection, whereas a non-phosphorylated peptide should not affect binding. For example, in BT-lab's antibody validation, they showed that "the picture on the right is blocked with the phospho peptide" .

  • Phosphatase treatment controls: Treat sample aliquots with lambda phosphatase before immunoblotting to demonstrate that antibody recognition is phosphorylation-dependent.

  • Mutant HSF1 expression: Express T142A mutant HSF1 in cells with endogenous HSF1 knocked down. The phospho-specific antibody should not recognize the mutant protein even under conditions that normally induce phosphorylation.

  • Kinase modulation: Use AKT1 inhibitors or activators to modulate Thr142 phosphorylation and confirm corresponding changes in antibody signal.

  • Cross-reactivity testing: Test the antibody against other phosphorylated proteins, particularly those with similar phosphorylation motifs, to ensure specificity.

  • Comparison across techniques: Validate antibody performance across multiple techniques (western blot, IHC, IF, ELISA) to ensure consistent results.

What are the optimal experimental conditions for detecting HSF1 phosphorylation at Thr142?

To optimize detection of HSF1 phosphorylation at Thr142, consider these methodological factors:

  • Stress induction protocols:

    • Heat shock: 42°C for 1 hour typically increases HSF1 phosphorylation by 2.5-4 fold

    • Other stressors: Oxidative stress, heavy metals, or proteotoxic compounds can also induce HSF1 phosphorylation

  • Timing of analysis: HSF1 phosphorylation is dynamic during stress response, so collect samples at multiple time points (e.g., 15, 30, 60, 120 minutes after stress) to capture peak phosphorylation.

  • Sample preparation:

    • Include phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate) in lysis buffers

    • Perform nuclear fractionation, as phosphorylated HSF1 tends to accumulate in the nucleus

    • Use rapid sample processing to prevent dephosphorylation

  • Application-specific optimizations:

    • For IHC: Use dilutions of 1:50-1:100

    • For ELISA: Use dilutions around 1:20000

    • For IF: Special attention to fixation method is critical (paraformaldehyde typically works well)

  • Positive controls: Include samples from cells with activated AKT1 signaling, which increases Thr142 phosphorylation .

How can I distinguish between the roles of Thr142 phosphorylation and other phosphorylation sites in HSF1 activation?

To distinguish between the roles of different HSF1 phosphorylation sites:

  • Phosphorylation-specific antibody panels: Use antibodies targeting different phosphorylation sites (Thr142, Ser326, Ser230, Ser303, etc.) to monitor their temporal and stress-specific patterns.

  • Mutagenesis approaches:

    • Single-site mutations: Compare T142A to S326A, S230A, and other site mutants

    • Phosphomimetic mutations: T142D/E versus other phosphomimetic mutants

    • Combinatorial mutations: Create double or triple mutants to assess interactions

  • Functional readouts across sites:

    • DNA binding assays (EMSA or ChIP)

    • Trimerization assays

    • Nuclear localization

    • Transcriptional reporter assays

    • HSP gene expression analysis

  • Kinase-specific manipulations: Target specific kinases known to phosphorylate different sites:

    • AKT1 for Thr142

    • CaMKII for Ser230

    • Other kinases like p38, MK2, or CK2 for other sites

  • Phosphatase targeting: Use phosphatase inhibitors or overexpression to assess site-specific dephosphorylation rates.

What are the key considerations for monitoring HSF1 Thr142 phosphorylation dynamics during different stress responses?

For effective monitoring of HSF1 Thr142 phosphorylation dynamics during stress responses:

  • Temporal resolution: Implement fine-grained time-course analyses (e.g., samples every 5-15 minutes during the first hour of stress) to capture rapid phosphorylation changes.

  • Stress-specific protocols:

    • Heat shock: Monitor temperature precisely and control exposure time

    • Oxidative stress: Titrate H₂O₂ or other oxidants to ensure sub-lethal stress

    • Proteotoxic stress: Determine optimal concentrations of proteasome inhibitors

  • Recovery dynamics: Include post-stress recovery time points to understand how Thr142 phosphorylation is regulated during adaptation.

  • Subcellular fractionation: Compare phosphorylation levels in cytoplasmic versus nuclear fractions, as HSF1 undergoes nucleocytoplasmic shuttling during activation.

  • Pathway inhibitors: Use specific inhibitors to dissect upstream pathways:

    • PI3K/AKT inhibitors to block AKT1-mediated phosphorylation

    • MAPK pathway inhibitors

    • mTORC inhibitors

  • Correlation with HSF1 activity markers:

    • HSF1 DNA binding (by ChIP)

    • Target gene expression (HSP70, HSP90, etc.)

    • HSF1 trimerization status

What are common challenges in interpreting Phospho-HSF1 (Thr142) antibody results and how can they be addressed?

Researchers face several challenges when interpreting Phospho-HSF1 (Thr142) antibody results:

  • Multiple HSF1 bands on Western blots: HSF1 often appears as multiple bands due to:

    • Various phosphorylation states (heat shock increases phosphorylation 2.5-4 fold )

    • Different isoforms and splice variants

    • Partial proteolysis during sample preparation

    Solution: Include phosphatase-treated controls and use isoform-specific antibodies alongside phospho-specific antibodies.

  • Cross-reactivity with other phosphorylated proteins: Some antibodies may recognize similar phosphorylation motifs in other proteins.

    Solution: Validate with HSF1 knockout/knockdown controls and peptide competition assays .

  • Variable phosphorylation levels across cell types: Different cell types show different baseline and stress-induced phosphorylation patterns.

    Solution: Include appropriate cell type-specific positive controls and standardize stress conditions carefully.

  • Antibody lot-to-lot variation: Different production lots may show varying specificity and sensitivity.

    Solution: Validate each new lot against previously characterized lots using identical samples.

  • Phosphorylation status changes during sample processing: Rapid dephosphorylation can occur even in the presence of inhibitors.

    Solution: Use rapid sample processing protocols and snap-freezing when possible.

How do I design controls to ensure reliable interpretation of Phospho-HSF1 (Thr142) antibody experimental data?

Comprehensive control design for Phospho-HSF1 (Thr142) experiments should include:

  • Positive controls:

    • Heat-shocked samples (42°C for 1 hour increases phosphorylation 2.5-4 fold)

    • Cells with activated AKT1 signaling (increases Thr142 phosphorylation)

    • In vitro phosphorylated recombinant HSF1 (useful for antibody validation)

  • Negative controls:

    • Non-stressed samples for baseline comparison

    • Lambda phosphatase-treated samples to remove phosphorylation

    • T142A mutant HSF1 expression (cannot be phosphorylated at position 142)

    • Peptide competition controls (phosphopeptide should block antibody binding)

  • Specificity controls:

    • HSF1 knockout/knockdown samples to confirm band identity

    • Antibodies to total HSF1 run in parallel to confirm protein presence

    • Antibodies to other HSF1 phosphorylation sites to distinguish modification patterns

  • Experimental condition controls:

    • Kinase inhibitor treatments (e.g., AKT inhibitors)

    • Phosphatase inhibitor treatments

    • Time course sampling to capture dynamic changes

  • Technical controls:

    • Loading controls (β-actin, GAPDH, etc.)

    • Secondary antibody-only controls to detect non-specific binding

What quantification methods are most appropriate for analyzing HSF1 Thr142 phosphorylation in different experimental contexts?

For quantitative analysis of HSF1 Thr142 phosphorylation:

  • Western blot quantification:

    • Normalize phospho-HSF1 signal to total HSF1 rather than housekeeping proteins

    • Use digital imaging and quantification software with linear dynamic range

    • Implement replicate analysis (biological and technical) with statistical testing

    • Consider the ratio of different HSF1 bands (faster vs. slower migrating forms)

  • Immunohistochemistry/Immunofluorescence quantification:

    • Use digital image analysis with standardized thresholds

    • Quantify nuclear vs. cytoplasmic signal separately

    • Implement cell-by-cell analysis rather than field averages when possible

    • Consider co-localization with HSF1 nuclear granules

  • ELISA-based quantification:

    • Generate standard curves using phosphorylated recombinant HSF1

    • Perform parallel ELISAs for total HSF1 to calculate phosphorylation ratios

    • Use appropriate dilution series to ensure measurements fall within linear range

  • Phosphoproteomic approaches:

    • Use mass spectrometry to quantify phosphopeptides containing Thr142

    • Implement stable isotope labeling for comparing different conditions

    • Consider targeted MS approaches like parallel reaction monitoring for lower abundance phosphopeptides

  • Live-cell monitoring:

    • Develop phosphorylation-sensitive fluorescent reporters

    • Use FRET-based sensors for real-time phosphorylation monitoring

    • Implement computational modeling to integrate multiple phosphorylation sites

How is HSF1 Thr142 phosphorylation implicated in cancer biology and potential therapeutic approaches?

Emerging research shows HSF1 Thr142 phosphorylation has significant implications for cancer biology:

  • Cancer-specific HSF1 activation: HSF1 activity supports malignant transformation through both heat shock protein-dependent and independent mechanisms . Thr142 phosphorylation by AKT1 may be a critical node in this process, as the PI3K/AKT pathway is frequently hyperactivated in cancer.

  • Therapeutic targeting potential:

    • Inhibiting AKT1-mediated Thr142 phosphorylation could suppress HSF1 activation

    • Combination approaches targeting both Thr142 and other activating phosphorylation sites may enhance efficacy

    • Rational design of small molecules that specifically interfere with phosphorylation-dependent HSF1 trimerization

  • Biomarker applications:

    • Phospho-Thr142 HSF1 levels may serve as prognostic or predictive biomarkers

    • Ratios of different HSF1 phosphorylation states could indicate specific oncogenic pathway activation

  • Resistance mechanisms:

    • Stress-induced Thr142 phosphorylation may contribute to therapy resistance

    • Targeting this modification could potentially resensitize resistant tumors

  • Metabolic connections:

    • HSF1 influences cancer metabolism, and Thr142 phosphorylation may link metabolic stress sensing to transcriptional adaptation

    • The AKT-mTOR-HSF1 axis appears particularly relevant for integrating metabolic signals

What are the most promising methodological advances for studying HSF1 Thr142 phosphorylation in complex biological systems?

Emerging methodologies for studying HSF1 Thr142 phosphorylation include:

  • CRISPR-based approaches:

    • Knock-in of phosphorylation-site mutations at endogenous loci

    • Base editing to create T142A or other mutations without double-strand breaks

    • CRISPR activation/inhibition systems to modulate kinases/phosphatases affecting Thr142

  • Advanced imaging techniques:

    • Super-resolution microscopy to visualize phospho-HSF1 nuclear granules

    • Live-cell phosphorylation sensors based on conformation-sensitive fluorophores

    • Correlative light and electron microscopy to study phospho-HSF1 localization at ultrastructural level

  • Single-cell approaches:

    • Single-cell phosphoproteomics to capture cell-to-cell variability

    • Combined single-cell transcriptomics and phospho-protein analysis

    • Microfluidic approaches for temporal analysis of single-cell responses

  • Organoid and in vivo models:

    • Phospho-HSF1 analysis in patient-derived organoids

    • Genetically engineered mouse models with T142A or T142E mutations

    • Intravital imaging with phospho-specific biosensors

  • Computational methods:

    • Mathematical modeling of multi-site phosphorylation dynamics

    • Network analysis integrating phospho-HSF1 with downstream transcriptional targets

    • Machine learning approaches to predict context-dependent effects of Thr142 phosphorylation

How does HSF1 Thr142 phosphorylation integrate with other cellular stress response pathways?

The integration of HSF1 Thr142 phosphorylation with other stress response pathways reveals complex regulatory networks:

  • Crosstalk with metabolic stress pathways:

    • The AKT-mediated phosphorylation of Thr142 provides direct integration with insulin and growth factor signaling

    • AMPK, which phosphorylates HSF1 at Ser121 to suppress HSR during metabolic stress , may influence Thr142 phosphorylation dynamics

  • Integration with proteostasis networks:

    • Phosphorylation at Thr142 influences HSF1 trimerization, directly affecting chaperone expression

    • The negative feedback loop through HSP70, HSC70, and HSP40 (DNAJB1) may be modulated by Thr142 phosphorylation status

  • Interaction with cell survival pathways:

    • AKT1 promotes both cell survival and HSF1 activation through Thr142 phosphorylation

    • This may represent a mechanism to coordinate proteostasis with anti-apoptotic programs

  • Relationship with other transcription factors:

    • Potential coordinated regulation with NRF2 (oxidative stress)

    • Interaction with hypoxia response pathways through HIF1α

    • Cross-regulation with inflammatory pathways through NF-κB

  • Connection to cellular senescence and aging:

    • HSF1 plays a role in lifespan regulation

    • Thr142 phosphorylation status may change during aging, affecting stress resilience

    • Potential therapeutic target for age-related protein folding diseases

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.